Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease
- Authors: Milovanova LY.1, Milovanov Y.S1, Kudryavtseva DV1, Markina MM1, Milovanova SY.1, Kozlovskaya LV1, Lebedeva MV1, Beketov VD1, Moiseev SV1, Mukhin NA1, Fomin VV1, Svistunov AA1
-
Affiliations:
- «Первый МГМУ им. И.М. Сеченова» Минздрава России
- Issue: Vol 87, No 6 (2015)
- Pages: 10-16
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/31737
- ID: 31737
Cite item
Full Text
Abstract
About the authors
L Yu Milovanova
«Первый МГМУ им. И.М. Сеченова» Минздрава РоссииМосква, Россия
Yu S Milovanov
«Первый МГМУ им. И.М. Сеченова» Минздрава РоссииМосква, Россия
D V Kudryavtseva
«Первый МГМУ им. И.М. Сеченова» Минздрава РоссииМосква, Россия
M M Markina
«Первый МГМУ им. И.М. Сеченова» Минздрава РоссииМосква, Россия
S Yu Milovanova
«Первый МГМУ им. И.М. Сеченова» Минздрава РоссииМосква, Россия
L V Kozlovskaya
«Первый МГМУ им. И.М. Сеченова» Минздрава РоссииМосква, Россия
M V Lebedeva
«Первый МГМУ им. И.М. Сеченова» Минздрава РоссииМосква, Россия
V D Beketov
«Первый МГМУ им. И.М. Сеченова» Минздрава РоссииМосква, Россия
S V Moiseev
«Первый МГМУ им. И.М. Сеченова» Минздрава РоссииМосква, Россия
N A Mukhin
«Первый МГМУ им. И.М. Сеченова» Минздрава РоссииМосква, Россия
V V Fomin
«Первый МГМУ им. И.М. Сеченова» Минздрава РоссииМосква, Россия
A A Svistunov
«Первый МГМУ им. И.М. Сеченова» Минздрава РоссииМосква, Россия
References
- Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011;80(12):1258-1270.
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evalution, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int. 2009;76(Suppl.113):S1-S130.
- Milovanova L, Milovanov Y, Plotnikova A. Phosphorus and Calcium Metabolism Disorders Assosiated with Chronic Kidney Disease Stage III—IV (Systematic Rewiew and Meta-Analysis). Chronic Kidney Disease and renal Transplantation. Ed. by Manisha Sahay. INTECH; 2012:95-118.
- Kuo-Cheng Lu, Chia-Chao Wu, Jen-Fen Yen. Vascular calcification and Renal Bone Disorders. Scientific World J. 2014; Published online 2014 Jul 17. doi: 10.1155/2014/637065.
- Gutierrez OM, Januzzi JL, Isacova T, Laliberte K, Smith K, Collerone G, Sarwar A, Hoffmann U, Coglianese E, Christenson R, Wang TJ, deFilippi C, Wolf M. Fibroblast growth factor-23 and left ventricular hypertrophy in chronic kidney disease. Circulation. 2009;119(9):2545-2552.
- Kuro-o M. Klotho in chronic kidney disease — What’s new? Nephrol Dial Transplant. 2009;24(6):1705-1708.
- Hu MC, Shi M, Zhang J, Quiñones H, Griffith C, Kuro-o M, Moe OW. Klotho deficiency causes vascular calcification in chronic kidney disease. Am J Soc Nephrol. 2011;22(1):124-136.
- Ming Chang Hu, Makoto Kuro-o, Orson W Moe. Klotho and Chronic Kidney Disease. Contrib Nephrol. 2013;180:47-63.
- Ming Chang Hu, Makoto Kuro-o, Orson W Moe. Renal and extra-renal actions of klotho. Semin Nephrol. 2013;33:118-129.
- Silverman SL. Sclerostin. J Osteoporosis. 2010;3:94-99.
- Devereux RB. The value of noninvasive measurements in hypertension. J Am Med Assoc. 1990;264(2):2798-2799.
- Zhu D, Mackenzie NCW, Millán JL, Farquharson C, MacRae VE. The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells. PLoS ONE. 2011;6(5):67-71.
- Román-García P, Carrillo-López N, Fernández-Martín JL, Naves-Díaz M, Ruiz-Torres MP, Cannata-Andía JB. High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression. Bone. 2010;46(1):121-128.
- Agarwal I, Ide N, Ix JH, Kestenbaum B, Lanske B, Schiller NB, Whooley MA, Mukamal KJ. Fibroblast Growth Factor-23 and Cardiac Structure and Function. J Am Heart Assoc. 2014;3(1): 132-135.
- Scialla JJ, Xie H, Rahman M, Anderson AH, Isakova T, Ojo A, Zhang X, Nessel L, Hamano T, Grunwald JE, Raj DS, Yang W, He J, Lash JP, Go AS, Kusek JW, Feldman H, Wolf M; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators. Fibroblast Growth Factor-23 and Cardiovascular Events in CKD. J Am Soc Nephrol. 2014;25(2):349-360.
- Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C. High levels of serum Fibroblast Growth Factors (FGF)-23 are associated with increased mortality in long haemodialysis patients. Nephrol Dial Transplant. 2009;24:2792-2796.
- Mitani H, Ishizaka N, Aizawa T, Ohno M, Usui S, Suzuki T, Amaki T, Mori I, Nakamura Y, Sato M, Nangaku M, Hirata Y, Nagai R. In vivo Klotho gene transfer ameliorates angiotensin II-induced renal damage. Hypertension. 2002;39:838-843.
- Borst MH, Vervloet MG. Cross Talk Between the Renin-Angiotensin-Aldosterone System and Vitamin D-FGF-23-klotho in Chronic Kidney Disease. Am J Soc Nephrol. 2011;22(9):1603-1609.
![](/img/style/loading.gif)